Author:
Tiwari Meenakshi,Kumar Sharma Lokendra,Kumar Saxena Ajit
Abstract
High-grade glioma (HGG) such as glioblastoma multiforme (GBM) is an aggressive brain tumor that is still associated with poor prognosis. With the discovery and advancement in understanding of cancer stem cells (CSC) in glioma, these cells have emerged as seed cells for tumor growth and recurrence and appear as a potential target for therapeutics. Glioma stem cells (GSCs) demonstrate capacity of self-renewal, proliferation, and differentiation into multiple cell types and can contribute to tumor heterogeneity. Their role is established in tumorigenesis, metastasis, chemo- and radio-resistance and appears as a major cause for tumor recurrence. Thus, targeting GSCs by various therapeutics may improve effectiveness of the drugs in use alone or in combination to significantly improve patient survival outcome in GBM cases. In this chapter, we have discussed various mechanisms that drive GSC including signaling pathways and tumor microenvironment. We have also discussed the mechanism behind resistance of GSCs toward therapeutics and the pathways that can be targeted to improve the outcome of the patients.
Reference148 articles.
1. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005-2009 [published correction appears in Neuro Oncol. 2013 May;15(5):646-7]. Neuro-Oncology. 2012;14(Suppl 5):v1-v49. DOI: 10.1093/neuonc/nos218
2. Davis ME. Glioblastoma: Overview of disease and treatment. Clinical Journal of Oncology Nursing. 2016;20(5 Suppl):S2-S8. DOI: 10.1188/16.CJON.S1.2-8
3. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma Multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pacific Journal of Cancer Prevention. 2017;18(1):3-9. Published 2017 Jan 1. DOI: 10.22034/APJCP.2017.18.1.3
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105-111. DOI: 10.1038/35102167
5. Kang H, Lee H, Kim D, et al. Targeting glioblastoma stem cells to overcome Chemoresistance: An overview of current therapeutic strategies. Biomedicine. 2022;10(6):1308. Published 2022 Jun 2. DOI: 10.3390/biomedicines10061308